» Articles » PMID: 35370403

Health-Related Quality of Life and Its Influencing Factors in Patients with Coronary Heart Disease in China

Overview
Date 2022 Apr 4
PMID 35370403
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: This study aimed to comprehensively evaluate Chinese coronary heart disease (CHD) patients' health-related quality of life (HRQoL) using various measures and explore influencing factors associated with HRQoL.

Methods: A cross-sectional study was conducted from April to September 2019 in the General Hospital of Tianjin Medical University. A convenience sampling framework was used to successively recruit 316 inpatients with CHD. Two generic preference-based instruments (EQ-5D-5L and 15D), a disease-specific instrument (Seattle Angina Questionnaire, SAQ), and the WHO-5 well-being index (WHO-5) were administered. Tobit regression model and multiple linear regression were used for data analyses.

Results: A total of 305 patients (mean age was 62.9) with CHD participated in this study. The mean health state utility (HSU) scores of EQ-5D-5L and 15D were 0.85 (SD=0.14) and 0.89 (SD=0.07), respectively. For EQ-5D-5L, pain/discomfort was the most frequently reported, followed by anxiety/depression. As for 15D, discomfort and symptoms was the most severely impaired dimension. For SAQ, more limitations were found in the domains of angina stability and disease perception. For WHO-5, the mean score was 16.93. Marital status, disease state and comorbidity were influencing factors associated with HRQoL, patient's subjective well-being had a positive impact on HRQoL.

Conclusion: To improve the HRQoL of CHD patients in China, more attention needs to be paid to unmarried and relapsed patients, especially those with comorbidity of hypertension. Additionally, more social support and psychological counseling should be provided to patients.

Citing Articles

Cost-effectiveness of universal genetic screening for familial hypercholesterolemia in young adults aged 18-40 years in China.

Meng R, Shi F, Zhang B, Li C, Wang J, Song L BMC Med. 2025; 23(1):139.

PMID: 40045404 PMC: 11884056. DOI: 10.1186/s12916-025-03966-7.


Health-related quality of life with rivaroxaban plus aspirin vs. aspirin alone in chronic stable cardiovascular disease: Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial.

Xie F, Yan J, Eikelboom J, Anand S, Muehlhofer E, Pullenayegum E Eur Heart J Open. 2024; 4(5):oeae083.

PMID: 39439530 PMC: 11495100. DOI: 10.1093/ehjopen/oeae083.


The effect of escitalopram in treating mild to moderate depressive disorder and improving the quality of life in patients undergoing coronary artery bypass grafting - a double-blind randomized clinical trial.

Baradaran A, Ardakani M, Bateni F, Asadian-Koohestani F, Vahedi M, Aein A Front Psychiatry. 2024; 15:1342754.

PMID: 39006820 PMC: 11240843. DOI: 10.3389/fpsyt.2024.1342754.


Methodology and results of cost-effectiveness of LDL-C lowering with evolocumab in patients with acute myocardial infarction in China.

Wan Y, Liu J, Zhan X, Zhang Y, You R Cost Eff Resour Alloc. 2023; 21(1):93.

PMID: 38041072 PMC: 10690971. DOI: 10.1186/s12962-023-00501-4.


Factors associated with health-related quality of life in patients undergoing percutaneous coronary intervention: Thai PCI registry.

Siriyotha S, Pattanaprateep O, Srimahachota S, Sansanayudh N, Thakkinstian A, Limpijankit T Front Cardiovasc Med. 2023; 10:1260993.

PMID: 38028486 PMC: 10663305. DOI: 10.3389/fcvm.2023.1260993.


References
1.
. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100):1151-1210. PMC: 5605883. DOI: 10.1016/S0140-6736(17)32152-9. View

2.
Christian A, Cheema A, Smith S, Mosca L . Predictors of quality of life among women with coronary heart disease. Qual Life Res. 2006; 16(3):363-73. DOI: 10.1007/s11136-006-9135-7. View

3.
Luo N, Liu G, Li M, Guan H, Jin X, Rand-Hendriksen K . Estimating an EQ-5D-5L Value Set for China. Value Health. 2017; 20(4):662-669. DOI: 10.1016/j.jval.2016.11.016. View

4.
Zhou T, Guan H, Yao J, Xiong X, Ma A . The quality of life in Chinese population with chronic non-communicable diseases according to EQ-5D-3L: a systematic review. Qual Life Res. 2018; 27(11):2799-2814. PMC: 6208588. DOI: 10.1007/s11136-018-1928-y. View

5.
Jarab A, Almousa A, Rababah A, Mukattash T, Farha R . Health-related quality of life and its associated factors among patients with angina in Jordan. Qual Life Res. 2019; 29(4):1027-1035. DOI: 10.1007/s11136-019-02383-7. View